These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
30. Time-course studies of 14-3-3 protein isoforms in cerebrospinal fluid and brain of primates after oral or intracerebral infection with bovine spongiform encephalopathy agent. Yutzy B; Holznagel E; Coulibaly C; Stuke A; Hahmann U; Deslys JP; Hunsmann G; Löwer J J Gen Virol; 2007 Dec; 88(Pt 12):3469-3478. PubMed ID: 18024918 [TBL] [Abstract][Full Text] [Related]
31. Understanding Intra-Species and Inter-Species Prion Conversion and Zoonotic Potential Using Protein Misfolding Cyclic Amplification. Peden AH; Suleiman S; Barria MA Front Aging Neurosci; 2021; 13():716452. PubMed ID: 34413769 [TBL] [Abstract][Full Text] [Related]
32. Squirrel monkeys (Saimiri sciureus) infected with the agent of bovine spongiform encephalopathy develop tau pathology. Piccardo P; Cervenak J; Yakovleva O; Gregori L; Pomeroy K; Cook A; Muhammad FS; Seuberlich T; Cervenakova L; Asher DM J Comp Pathol; 2012 Jul; 147(1):84-93. PubMed ID: 22018806 [TBL] [Abstract][Full Text] [Related]
33. Accumulation of mono-glycosylated form-rich, plaque-forming PrPSc in the second atypical bovine spongiform encephalopathy case in Japan. Hagiwara K; Yamakawa Y; Sato Y; Nakamura Y; Tobiume M; Shinagawa M; Sata T Jpn J Infect Dis; 2007 Sep; 60(5):305-8. PubMed ID: 17881874 [TBL] [Abstract][Full Text] [Related]
34. Coexistence of two forms of disease-associated prion protein in extracerebral tissues of cattle infected with H-type bovine spongiform encephalopathy. Okada H; Miyazawa K; Masujin K; Yokoyama T J Vet Med Sci; 2016 Aug; 78(7):1189-93. PubMed ID: 27010466 [TBL] [Abstract][Full Text] [Related]
35. Testing the possibility to protect bovine PrPC transgenic Swiss mice against bovine PrPSc infection by DNA vaccination using recombinant plasmid vectors harboring and expressing the complete or partial cDNA sequences of bovine PrPC. Müller S; Kehm R; Handermann M; Jakob NJ; Bahr U; Schröder B; Darai G Virus Genes; 2005 Mar; 30(2):279-96. PubMed ID: 15744583 [TBL] [Abstract][Full Text] [Related]
36. Discrimination between prion-infected and normal blood samples by protein misfolding cyclic amplification. Tattum MH; Jones S; Pal S; Collinge J; Jackson GS Transfusion; 2010 May; 50(5):996-1002. PubMed ID: 20180925 [TBL] [Abstract][Full Text] [Related]
37. Tissue distribution of protease resistant prion protein in variant Creutzfeldt-Jakob disease using a highly sensitive immunoblotting assay. Wadsworth JD; Joiner S; Hill AF; Campbell TA; Desbruslais M; Luthert PJ; Collinge J Lancet; 2001 Jul; 358(9277):171-80. PubMed ID: 11476832 [TBL] [Abstract][Full Text] [Related]
38. Unaltered susceptibility to BSE in transgenic mice expressing human prion protein. Collinge J; Palmer MS; Sidle KC; Hill AF; Gowland I; Meads J; Asante E; Bradley R; Doey LJ; Lantos PL Nature; 1995 Dec 21-28; 378(6559):779-83. PubMed ID: 8524411 [TBL] [Abstract][Full Text] [Related]
39. Prions in the urine of patients with variant Creutzfeldt-Jakob disease. Moda F; Gambetti P; Notari S; Concha-Marambio L; Catania M; Park KW; Maderna E; Suardi S; Haïk S; Brandel JP; Ironside J; Knight R; Tagliavini F; Soto C N Engl J Med; 2014 Aug; 371(6):530-9. PubMed ID: 25099577 [TBL] [Abstract][Full Text] [Related]
40. Prions in the peripheral nerves of bovine spongiform encephalopathy-affected cattle. Masujin K; Matthews D; Wells GAH; Mohri S; Yokoyama T J Gen Virol; 2007 Jun; 88(Pt 6):1850-1858. PubMed ID: 17485547 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]